Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows

Metronomic chemotherapy (mCHT), defined as continuous administration of low-dose chemotherapeutic agents with no or short regular treatment-free intervals, was first introduced to the clinic in international guidelines in 2017, and, since then, has become one of the available strategies for the trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Cazzaniga, Marina Elena, Capici, Serena, Cordani, Nicoletta, Cogliati, Viola, Pepe, Francesca Fulvia, Riva, Francesca, Cerrito, Maria Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410269/
https://www.ncbi.nlm.nih.gov/pubmed/36012949
http://dx.doi.org/10.3390/jcm11164710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410269/
https://www.ncbi.nlm.nih.gov/pubmed/36012949
http://dx.doi.org/10.3390/jcm11164710

Ejemplares similares